Evidence map›Paper›PMID 26691898›Full record

ArticleEmerging infectious diseases2016

Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers' Diarrhea.

Anu Kantele, Sointu Mero, Juha Kirveskari, Tinja Lääveri

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Bringing home unwelcome souvenirs: Travel and drug-resistant bacteria.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2018
    Article
  12. Travel and the Spread of Drug-Resistant Bacteria.Current infectious disease reports · 2018
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Anu Kantele
Sointu Mero
Juha Kirveskari
Tinja Lääveri
Helsinki University Hospital · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial drug treatment of travelers' diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers' diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%.

Indexed as

AdultAnti-Infective Agentsbeta-LactamasesDiarrheaEnterobacteriaceaeFemaleHumansLoperamideMaleRiskTravelAnti-Infective Agentsbeta-LactamasesLoperamideAMDantibiotic resistanceantibioticsantidiarrhealantimicrobial drugsantimicrobial resistancediarrheaESBLextended-spectrum beta-lactamase–producing Enterobacteriaceaeloperamidetraveltravelers’ diarrheatravel healthtravel medicine

Identifiers

PMID26691898
PMCPMC4696706
OpenAlexW2285188499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.